Israel vs Turkmenistan: New cases tested for RR-/MDR-TB
Israel
100.0%
in 2024
Turkmenistan
100.0%
in 2022
Israel rank
1st
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- Israel
- Turkmenistan
How they compare
Israel currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 1 time across 8 shared years of data; in 2006 it was Israel ahead.
Israel ranks 1st and Turkmenistan ranks 1st of 192 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 6.0% | 94.0% | Israel |
| 2010s | 100.0% | 45.0% | 55.0% | Israel |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Israel or Turkmenistan?
- Israel, at 100.0% against 100.0% in Turkmenistan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Israel and Turkmenistan?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Turkmenistan?
- 8 years are reported by both, from 2006 to 2022.
- How do Israel and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- Israel ranks 1st and Turkmenistan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.